Global Microbiome Therapeutics Market Insights and Forecast to 2028

Global Microbiome Therapeutics Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiome Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Upper GIT
1.2.3 Lower GIT
1.3 Market by Application
1.3.1 Global Microbiome Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 C. difficile Infection (CDI)
1.3.3 Inflammatory Bowel Disease (IBD)
1.3.4 Orphan Drug
1.3.5 Immuno-oncology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Microbiome Therapeutics Market Perspective (2017-2028)
2.2 Microbiome Therapeutics Growth Trends by Region
2.2.1 Microbiome Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Microbiome Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Microbiome Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Microbiome Therapeutics Market Dynamics
2.3.1 Microbiome Therapeutics Industry Trends
2.3.2 Microbiome Therapeutics Market Drivers
2.3.3 Microbiome Therapeutics Market Challenges
2.3.4 Microbiome Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbiome Therapeutics Players by Revenue
3.1.1 Global Top Microbiome Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Microbiome Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Microbiome Therapeutics Revenue
3.4 Global Microbiome Therapeutics Market Concentration Ratio
3.4.1 Global Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiome Therapeutics Revenue in 2021
3.5 Microbiome Therapeutics Key Players Head office and Area Served
3.6 Key Players Microbiome Therapeutics Product Solution and Service
3.7 Date of Enter into Microbiome Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Microbiome Therapeutics Breakdown Data by Type
4.1 Global Microbiome Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Microbiome Therapeutics Forecasted Market Size by Type (2023-2028)
5 Microbiome Therapeutics Breakdown Data by Application
5.1 Global Microbiome Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Microbiome Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Microbiome Therapeutics Market Size (2017-2028)
6.2 North America Microbiome Therapeutics Market Size by Type
6.2.1 North America Microbiome Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Microbiome Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Microbiome Therapeutics Market Share by Type (2017-2028)
6.3 North America Microbiome Therapeutics Market Size by Application
6.3.1 North America Microbiome Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Microbiome Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Microbiome Therapeutics Market Share by Application (2017-2028)
6.4 North America Microbiome Therapeutics Market Size by Country
6.4.1 North America Microbiome Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Microbiome Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Microbiome Therapeutics Market Size (2017-2028)
7.2 Europe Microbiome Therapeutics Market Size by Type
7.2.1 Europe Microbiome Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Microbiome Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Microbiome Therapeutics Market Share by Type (2017-2028)
7.3 Europe Microbiome Therapeutics Market Size by Application
7.3.1 Europe Microbiome Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Microbiome Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Microbiome Therapeutics Market Share by Application (2017-2028)
7.4 Europe Microbiome Therapeutics Market Size by Country
7.4.1 Europe Microbiome Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Microbiome Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Microbiome Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Microbiome Therapeutics Market Size by Type
8.2.1 Asia-Pacific Microbiome Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Microbiome Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Microbiome Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Microbiome Therapeutics Market Size by Application
8.3.1 Asia-Pacific Microbiome Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Microbiome Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Microbiome Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Microbiome Therapeutics Market Size by Region
8.4.1 Asia-Pacific Microbiome Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Microbiome Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Microbiome Therapeutics Market Size (2017-2028)
9.2 Latin America Microbiome Therapeutics Market Size by Type
9.2.1 Latin America Microbiome Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Microbiome Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Microbiome Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Microbiome Therapeutics Market Size by Application
9.3.1 Latin America Microbiome Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Microbiome Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Microbiome Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Microbiome Therapeutics Market Size by Country
9.4.1 Latin America Microbiome Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Microbiome Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbiome Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Microbiome Therapeutics Market Size by Type
10.2.1 Middle East & Africa Microbiome Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Microbiome Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Microbiome Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Microbiome Therapeutics Market Size by Application
10.3.1 Middle East & Africa Microbiome Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Microbiome Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Microbiome Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Microbiome Therapeutics Market Size by Country
10.4.1 Middle East & Africa Microbiome Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Microbiome Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Seres Therapeutics
11.1.1 Seres Therapeutics Company Details
11.1.2 Seres Therapeutics Business Overview
11.1.3 Seres Therapeutics Microbiome Therapeutics Introduction
11.1.4 Seres Therapeutics Revenue in Microbiome Therapeutics Business (2017-2022)
11.1.5 Seres Therapeutics Recent Developments
11.2 Assembly Biosciences
11.2.1 Assembly Biosciences Company Details
11.2.2 Assembly Biosciences Business Overview
11.2.3 Assembly Biosciences Microbiome Therapeutics Introduction
11.2.4 Assembly Biosciences Revenue in Microbiome Therapeutics Business (2017-2022)
11.2.5 Assembly Biosciences Recent Developments
11.3 Synthetic Biologics
11.3.1 Synthetic Biologics Company Details
11.3.2 Synthetic Biologics Business Overview
11.3.3 Synthetic Biologics Microbiome Therapeutics Introduction
11.3.4 Synthetic Biologics Revenue in Microbiome Therapeutics Business (2017-2022)
11.3.5 Synthetic Biologics Recent Developments
11.4 Interxon
11.4.1 Interxon Company Details
11.4.2 Interxon Business Overview
11.4.3 Interxon Microbiome Therapeutics Introduction
11.4.4 Interxon Revenue in Microbiome Therapeutics Business (2017-2022)
11.4.5 Interxon Recent Developments
11.5 PureTech
11.5.1 PureTech Company Details
11.5.2 PureTech Business Overview
11.5.3 PureTech Microbiome Therapeutics Introduction
11.5.4 PureTech Revenue in Microbiome Therapeutics Business (2017-2022)
11.5.5 PureTech Recent Developments
11.6 Synlogic
11.6.1 Synlogic Company Details
11.6.2 Synlogic Business Overview
11.6.3 Synlogic Microbiome Therapeutics Introduction
11.6.4 Synlogic Revenue in Microbiome Therapeutics Business (2017-2022)
11.6.5 Synlogic Recent Developments
11.7 Enterome BioScience
11.7.1 Enterome BioScience Company Details
11.7.2 Enterome BioScience Business Overview
11.7.3 Enterome BioScience Microbiome Therapeutics Introduction
11.7.4 Enterome BioScience Revenue in Microbiome Therapeutics Business (2017-2022)
11.7.5 Enterome BioScience Recent Developments
11.8 4D Pharma
11.8.1 4D Pharma Company Details
11.8.2 4D Pharma Business Overview
11.8.3 4D Pharma Microbiome Therapeutics Introduction
11.8.4 4D Pharma Revenue in Microbiome Therapeutics Business (2017-2022)
11.8.5 4D Pharma Recent Developments
11.9 Second Genome
11.9.1 Second Genome Company Details
11.9.2 Second Genome Business Overview
11.9.3 Second Genome Microbiome Therapeutics Introduction
11.9.4 Second Genome Revenue in Microbiome Therapeutics Business (2017-2022)
11.9.5 Second Genome Recent Developments
11.10 AOBiome
11.10.1 AOBiome Company Details
11.10.2 AOBiome Business Overview
11.10.3 AOBiome Microbiome Therapeutics Introduction
11.10.4 AOBiome Revenue in Microbiome Therapeutics Business (2017-2022)
11.10.5 AOBiome Recent Developments
11.11 C3 Jian
11.11.1 C3 Jian Company Details
11.11.2 C3 Jian Business Overview
11.11.3 C3 Jian Microbiome Therapeutics Introduction
11.11.4 C3 Jian Revenue in Microbiome Therapeutics Business (2017-2022)
11.11.5 C3 Jian Recent Developments
11.12 Rebiotix
11.12.1 Rebiotix Company Details
11.12.2 Rebiotix Business Overview
11.12.3 Rebiotix Microbiome Therapeutics Introduction
11.12.4 Rebiotix Revenue in Microbiome Therapeutics Business (2017-2022)
11.12.5 Rebiotix Recent Developments
11.13 MicroBiome Therapeutics LLC
11.13.1 MicroBiome Therapeutics LLC Company Details
11.13.2 MicroBiome Therapeutics LLC Business Overview
11.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Introduction
11.13.4 MicroBiome Therapeutics LLC Revenue in Microbiome Therapeutics Business (2017-2022)
11.13.5 MicroBiome Therapeutics LLC Recent Developments
11.14 Metabiomics
11.14.1 Metabiomics Company Details
11.14.2 Metabiomics Business Overview
11.14.3 Metabiomics Microbiome Therapeutics Introduction
11.14.4 Metabiomics Revenue in Microbiome Therapeutics Business (2017-2022)
11.14.5 Metabiomics Recent Developments
11.15 Ritter Pharmaceuticals
11.15.1 Ritter Pharmaceuticals Company Details
11.15.2 Ritter Pharmaceuticals Business Overview
11.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Introduction
11.15.4 Ritter Pharmaceuticals Revenue in Microbiome Therapeutics Business (2017-2022)
11.15.5 Ritter Pharmaceuticals Recent Developments
11.16 Symberix
11.16.1 Symberix Company Details
11.16.2 Symberix Business Overview
11.16.3 Symberix Microbiome Therapeutics Introduction
11.16.4 Symberix Revenue in Microbiome Therapeutics Business (2017-2022)
11.16.5 Symberix Recent Developments
11.17 OpenBiome
11.17.1 OpenBiome Company Details
11.17.2 OpenBiome Business Overview
11.17.3 OpenBiome Microbiome Therapeutics Introduction
11.17.4 OpenBiome Revenue in Microbiome Therapeutics Business (2017-2022)
11.17.5 OpenBiome Recent Developments
11.18 Azitra
11.18.1 Azitra Company Details
11.18.2 Azitra Business Overview
11.18.3 Azitra Microbiome Therapeutics Introduction
11.18.4 Azitra Revenue in Microbiome Therapeutics Business (2017-2022)
11.18.5 Azitra Recent Developments
11.19 Symbiotix Biotherapies
11.19.1 Symbiotix Biotherapies Company Details
11.19.2 Symbiotix Biotherapies Business Overview
11.19.3 Symbiotix Biotherapies Microbiome Therapeutics Introduction
11.19.4 Symbiotix Biotherapies Revenue in Microbiome Therapeutics Business (2017-2022)
11.19.5 Symbiotix Biotherapies Recent Developments
11.20 Osel
11.20.1 Osel Company Details
11.20.2 Osel Business Overview
11.20.3 Osel Microbiome Therapeutics Introduction
11.20.4 Osel Revenue in Microbiome Therapeutics Business (2017-2022)
11.20.5 Osel Recent Developments
11.21 Metabogen
11.21.1 Metabogen Company Details
11.21.2 Metabogen Business Overview
11.21.3 Metabogen Microbiome Therapeutics Introduction
11.21.4 Metabogen Revenue in Microbiome Therapeutics Business (2017-2022)
11.21.5 Metabogen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Microbiome Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Upper GIT
Table 3. Key Players of Lower GIT
Table 4. Global Microbiome Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Microbiome Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Microbiome Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Microbiome Therapeutics Market Share by Region (2017-2022)
Table 8. Global Microbiome Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Microbiome Therapeutics Market Share by Region (2023-2028)
Table 10. Microbiome Therapeutics Market Trends
Table 11. Microbiome Therapeutics Market Drivers
Table 12. Microbiome Therapeutics Market Challenges
Table 13. Microbiome Therapeutics Market Restraints
Table 14. Global Microbiome Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Microbiome Therapeutics Revenue Share by Players (2017-2022)
Table 16. Global Top Microbiome Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics as of 2021)
Table 17. Ranking of Global Top Microbiome Therapeutics Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Microbiome Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Microbiome Therapeutics Product Solution and Service
Table 21. Date of Enter into Microbiome Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Microbiome Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Microbiome Therapeutics Revenue Market Share by Type (2017-2022)
Table 25. Global Microbiome Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Microbiome Therapeutics Revenue Market Share by Type (2023-2028)
Table 27. Global Microbiome Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Microbiome Therapeutics Revenue Share by Application (2017-2022)
Table 29. Global Microbiome Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Microbiome Therapeutics Revenue Share by Application (2023-2028)
Table 31. North America Microbiome Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Microbiome Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Microbiome Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Microbiome Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Microbiome Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Microbiome Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Microbiome Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Microbiome Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Microbiome Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Microbiome Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Microbiome Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Microbiome Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Microbiome Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Microbiome Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Microbiome Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Microbiome Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Microbiome Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Microbiome Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Microbiome Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Microbiome Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Microbiome Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Microbiome Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Microbiome Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Microbiome Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Microbiome Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Microbiome Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Microbiome Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Microbiome Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Microbiome Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Microbiome Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 61. Seres Therapeutics Company Details
Table 62. Seres Therapeutics Business Overview
Table 63. Seres Therapeutics Microbiome Therapeutics Product
Table 64. Seres Therapeutics Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 65. Seres Therapeutics Recent Developments
Table 66. Assembly Biosciences Company Details
Table 67. Assembly Biosciences Business Overview
Table 68. Assembly Biosciences Microbiome Therapeutics Product
Table 69. Assembly Biosciences Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 70. Assembly Biosciences Recent Developments
Table 71. Synthetic Biologics Company Details
Table 72. Synthetic Biologics Business Overview
Table 73. Synthetic Biologics Microbiome Therapeutics Product
Table 74. Synthetic Biologics Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 75. Synthetic Biologics Recent Developments
Table 76. Interxon Company Details
Table 77. Interxon Business Overview
Table 78. Interxon Microbiome Therapeutics Product
Table 79. Interxon Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 80. Interxon Recent Developments
Table 81. PureTech Company Details
Table 82. PureTech Business Overview
Table 83. PureTech Microbiome Therapeutics Product
Table 84. PureTech Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 85. PureTech Recent Developments
Table 86. Synlogic Company Details
Table 87. Synlogic Business Overview
Table 88. Synlogic Microbiome Therapeutics Product
Table 89. Synlogic Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 90. Synlogic Recent Developments
Table 91. Enterome BioScience Company Details
Table 92. Enterome BioScience Business Overview
Table 93. Enterome BioScience Microbiome Therapeutics Product
Table 94. Enterome BioScience Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 95. Enterome BioScience Recent Developments
Table 96. 4D Pharma Company Details
Table 97. 4D Pharma Business Overview
Table 98. 4D Pharma Microbiome Therapeutics Product
Table 99. 4D Pharma Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 100. 4D Pharma Recent Developments
Table 101. Second Genome Company Details
Table 102. Second Genome Business Overview
Table 103. Second Genome Microbiome Therapeutics Product
Table 104. Second Genome Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 105. Second Genome Recent Developments
Table 106. AOBiome Company Details
Table 107. AOBiome Business Overview
Table 108. AOBiome Microbiome Therapeutics Product
Table 109. AOBiome Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 110. AOBiome Recent Developments
Table 111. C3 Jian Company Details
Table 112. C3 Jian Business Overview
Table 113. C3 Jian Microbiome Therapeutics Product
Table 114. C3 Jian Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 115. C3 Jian Recent Developments
Table 116. Rebiotix Company Details
Table 117. Rebiotix Business Overview
Table 118. Rebiotix Microbiome Therapeutics Product
Table 119. Rebiotix Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 120. Rebiotix Recent Developments
Table 121. MicroBiome Therapeutics LLC Company Details
Table 122. MicroBiome Therapeutics LLC Business Overview
Table 123. MicroBiome Therapeutics LLC Microbiome Therapeutics Product
Table 124. MicroBiome Therapeutics LLC Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 125. MicroBiome Therapeutics LLC Recent Developments
Table 126. Metabiomics Company Details
Table 127. Metabiomics Business Overview
Table 128. Metabiomics Microbiome Therapeutics Product
Table 129. Metabiomics Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 130. Metabiomics Recent Developments
Table 131. Ritter Pharmaceuticals Company Details
Table 132. Ritter Pharmaceuticals Business Overview
Table 133. Ritter Pharmaceuticals Microbiome Therapeutics Product
Table 134. Ritter Pharmaceuticals Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 135. Ritter Pharmaceuticals Recent Developments
Table 136. Symberix Company Details
Table 137. Symberix Business Overview
Table 138. Symberix Microbiome Therapeutics Product
Table 139. Symberix Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 140. Symberix Recent Developments
Table 141. OpenBiome Company Details
Table 142. OpenBiome Business Overview
Table 143. OpenBiome Microbiome Therapeutics Product
Table 144. OpenBiome Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 145. OpenBiome Recent Developments
Table 146. Azitra Company Details
Table 147. Azitra Business Overview
Table 148. Azitra Microbiome Therapeutics Product
Table 149. Azitra Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 150. Azitra Recent Developments
Table 151. Symbiotix Biotherapies Company Details
Table 152. Symbiotix Biotherapies Business Overview
Table 153. Symbiotix Biotherapies Microbiome Therapeutics Product
Table 154. Symbiotix Biotherapies Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 155. Symbiotix Biotherapies Recent Developments
Table 156. Osel Company Details
Table 157. Osel Business Overview
Table 158. Osel Microbiome Therapeutics Product
Table 159. Osel Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 160. Osel Recent Developments
Table 161. Metabogen Company Details
Table 162. Metabogen Business Overview
Table 163. Metabogen Microbiome Therapeutics Product
Table 164. Metabogen Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
Table 165. Metabogen Recent Developments
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Microbiome Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Upper GIT Features
Figure 3. Lower GIT Features
Figure 4. Global Microbiome Therapeutics Market Share by Application: 2021 VS 2028
Figure 5. C. difficile Infection (CDI) Case Studies
Figure 6. Inflammatory Bowel Disease (IBD) Case Studies
Figure 7. Orphan Drug Case Studies
Figure 8. Immuno-oncology Case Studies
Figure 9. Others Case Studies
Figure 10. Microbiome Therapeutics Report Years Considered
Figure 11. Global Microbiome Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Microbiome Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Microbiome Therapeutics Market Share by Region: 2021 VS 2028
Figure 14. Global Microbiome Therapeutics Market Share by Players in 2021
Figure 15. Global Top Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Microbiome Therapeutics Revenue in 2021
Figure 17. North America Microbiome Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Microbiome Therapeutics Market Size Market Share by Type (2017-2028)
Figure 19. North America Microbiome Therapeutics Market Size Market Share by Application (2017-2028)
Figure 20. North America Microbiome Therapeutics Market Size Share by Country (2017-2028)
Figure 21. United States Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Microbiome Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Microbiome Therapeutics Market Size Market Share by Type (2017-2028)
Figure 25. Europe Microbiome Therapeutics Market Size Market Share by Application (2017-2028)
Figure 26. Europe Microbiome Therapeutics Market Size Share by Country (2017-2028)
Figure 27. Germany Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Microbiome Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Microbiome Therapeutics Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Microbiome Therapeutics Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Microbiome Therapeutics Market Size Share by Region (2017-2028)
Figure 37. China Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Microbiome Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Microbiome Therapeutics Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Microbiome Therapeutics Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Microbiome Therapeutics Market Size Share by Country (2017-2028)
Figure 47. Mexico Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Microbiome Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Microbiome Therapeutics Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Microbiome Therapeutics Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Microbiome Therapeutics Market Size Share by Country (2017-2028)
Figure 53. Turkey Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Seres Therapeutics Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
Figure 57. Assembly Biosciences Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
Figure 58. Synthetic Biologics Revenue Growth Rate in Microbiome Therapeutics Business (2017-202

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Thyroid Gland Disorders Treatment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 80

Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to The thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When The thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, The body metabolism and functioning will be disrupted. The global Thyroid Gland Disorders Treatment market was valued at US$ 2950 million in 2023 and is anticipated to reach US$ 3871.9 million by 2030, witnessing a CAGR o......

Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98

According to our LPI (LP Information) latest study, the global Brachytherapy Afterloaders, Brachytherapy Seeds market size was valued at US$ 150.8 million in 2023. With growing demand in downstream market, the Brachytherapy Afterloaders, Brachytherapy Seeds is forecast to a readjusted size of US$ 168.1 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Brachytherapy Afterloaders, Brachytherapy Seeds market. Brachyth......

Global Peptide Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Peptide Therapeutics market size was valued at US$ 33800 million in 2023. With growing demand in downstream market, the Peptide Therapeutics is forecast to a readjusted size of US$ 63130 million by 2030 with a CAGR of 9.3% during review period. The research report highlights the growth potential of the global Peptide Therapeutics market. Peptide Therapeutics are expected to show stable growth in the future market. However, pr......

Global Microbiome Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Microbiome Therapeutics market size was valued at US$ 89 million in 2023. With growing demand in downstream market, the Microbiome Therapeutics is forecast to a readjusted size of US$ 916.3 million by 2030 with a CAGR of 39.5% during review period. The research report highlights the growth potential of the global Microbiome Therapeutics market. Microbiome Therapeutics are expected to show stable growth in the future market. H......

Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With growing demand in downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stabl......

Global Enzyme Replacement Therapy Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 113

According to our LPI (LP Information) latest study, the global Enzyme Replacement Therapy market size was valued at US$ 11570 million in 2023. With growing demand in downstream market, the Enzyme Replacement Therapy is forecast to a readjusted size of US$ 29900 million by 2030 with a CAGR of 14.5% during review period. The research report highlights the growth potential of the global Enzyme Replacement Therapy market. Enzyme Replacement Therapy are expected to show stable growth in the f......

Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 84

According to our LPI (LP Information) latest study, the global Infantile Spasms Therapeutics market size was valued at US$ 138.9 million in 2023. With growing demand in downstream market, the Infantile Spasms Therapeutics is forecast to a readjusted size of US$ 179.6 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Infantile Spasms Therapeutics market. Infantile Spasms Therapeutics are expected to show stable grow......

Global Hormone Replacement Therapy Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Hormone Replacement Therapy market size was valued at US$ 16090 million in 2023. With growing demand in downstream market, the Hormone Replacement Therapy is forecast to a readjusted size of US$ 17930 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Hormone Replacement Therapy market. Hormone Replacement Therapy are expected to show stable growth in th......

Global Plasma Therapy Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107

According to our LPI (LP Information) latest study, the global Plasma Therapy market size was valued at US$ 265.3 million in 2023. With growing demand in downstream market, the Plasma Therapy is forecast to a readjusted size of US$ 529.4 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Plasma Therapy market. Plasma Therapy are expected to show stable growth in the future market. However, product differentiation, ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs